Journey Medical (DERM) Income Statement (2020 - 2026)
Income Statement report data from Sep 30, 2020 to Mar 31, 2026 for Journey Medical (DERM).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||
Total Revenue | 16M (-0.93%) | 16M (-5.58%) | 17M (+13.39%) | 15M (+14.23%) | 13M (+4.12%) | 13M (-13.74%) | 15M (-1.55%) | 15M (+14.04%) | 13M (-14.61%) | 15M (-0.13%) | 15M (-9.91%) | 17M (+39.36%) | 12M (-23.56%) | 16M (-0.75%) | 16M (-12.06%) | 18M (-12.31%) | 21M (+18.72%) | 18M (-10.66%) | 20M (+28.25%) | 15M (+42.63%) | 11M (+13.44%) | 9.45M |
Cost Of Revenue | 6.22M (-61.44%) | 16M | - | - | 4.79M (+113.84%) | 2.24M (-57.66%) | 5.29M (-19.11%) | 6.54M (-4.11%) | 6.82M (+203.11%) | 2.25M (-65.01%) | 6.43M (-17.25%) | 7.77M (+20.47%) | 6.45M (-16.45%) | 7.72M (+6.93%) | 7.22M (-5.37%) | 7.63M (-6.95%) | 8.20M (-13.96%) | 9.53M (-14.68%) | 11M (+49.33%) | 7.48M (+91.30%) | 3.91M (+15.68%) | 3.38M |
Costof Goods And Services Sold | 6.22M (-61.44%) | 16M | - | - | 4.79M (+113.84%) | 2.24M (-57.66%) | 5.29M (-19.11%) | 6.54M (-4.11%) | 6.82M (+203.11%) | 2.25M (-65.01%) | 6.43M (-17.25%) | 7.77M (+20.47%) | 6.45M (-16.45%) | 7.72M (+6.93%) | 7.22M (-5.37%) | 7.63M (-6.95%) | 8.20M (-13.96%) | 9.53M (-14.68%) | 11M (+49.33%) | 7.48M (+91.30%) | 3.91M (+15.68%) | 3.38M |
Gross Profit | 9.70M (-69.66%) | 32M | - | - | 8.35M (-19.56%) | 10M (+11.13%) | 9.34M (+12.39%) | 8.31M (+33.82%) | 6.21M (-52.27%) | 13M (+47.01%) | 8.85M (-3.70%) | 9.19M (+60.66%) | 5.72M (-30.24%) | 8.20M (-7.03%) | 8.82M (-16.79%) | 11M (-15.81%) | 13M (+57.57%) | 7.99M (-5.33%) | 8.44M (+8.21%) | 7.80M (+14.54%) | 6.81M (+12.19%) | 6.07M |
Operating Expenses | ||||||||||||||||||||||
Research And Development | - | 150K (-48.28%) | 290K | - | 40K (-81.82%) | 220K (-73.81%) | 840K (-7.69%) | 910K (-88.45%) | 7.88M (+421.85%) | 1.51M (-32.29%) | 2.23M (+25.99%) | 1.77M (-12.81%) | 2.03M (-52.35%) | 4.26M (+51.60%) | 2.81M (+7.66%) | 2.61M (+105.51%) | 1.27M (-36.18%) | 1.99M (+176.39%) | 720K (+2300.00%) | 30K | - | - |
Selling General And Administrative | 10M (+2.54%) | 9.86M (-18.17%) | 12M (+1.43%) | 12M (+12.39%) | 11M (+5.07%) | 10M (-11.75%) | 11M (+10.36%) | 10M (+22.68%) | 8.42M (-14.43%) | 9.84M (+13.89%) | 8.64M (-28.83%) | 12M (-8.65%) | 13M (-5.00%) | 14M (-10.21%) | 16M (+2.57%) | 15M (+3.19%) | 15M (-2.26%) | 15M (+39.96%) | 11M (+37.95%) | 7.80M (+25.20%) | 6.23M (+6.86%) | 5.83M |
Operating Expenses | 17M (+5.63%) | 17M (-13.78%) | 19M (+7.10%) | 18M (+8.69%) | 16M (+44.51%) | 11M (-34.99%) | 18M (-1.46%) | 18M (-23.10%) | 23M (+33.18%) | 17M (+0.40%) | 17M (-30.37%) | 25M (+14.06%) | 22M (-16.14%) | 26M (+1.37%) | 26M (+0.71%) | 25M (+5.17%) | 24M (-9.00%) | 27M (-17.64%) | 32M (+11.05%) | 29M (+186.77%) | 10M (+9.99%) | 9.21M |
Operating Income | ||||||||||||||||||||||
Operating Income | -1.49M (+238.64%) | -440.00K (-71.24%) | -1.53M (-46.88%) | -2.88M (-13.25%) | -3.32M | 2.23M | -2.89M (-1.37%) | -2.93M (-70.96%) | -10.09M (+380.48%) | -2.10M | 17M | -7.65M (-19.98%) | -9.56M (-4.30%) | -9.99M (+5.27%) | -9.49M (+32.91%) | -7.14M (+702.25%) | -890.00K (-90.18%) | -9.06M (-28.38%) | -12.65M (-8.07%) | -13.76M | 590K (+145.83%) | 240K |
Ebit | -1.49M (+238.64%) | -440.00K (-71.24%) | -1.53M (-46.88%) | -2.88M (-13.25%) | -3.32M | 2.23M | -2.89M (-1.37%) | -2.93M (-70.96%) | -10.09M (+380.48%) | -2.10M | 17M | -7.65M (-19.98%) | -9.56M (-4.30%) | -9.99M (+5.27%) | -9.49M (+32.91%) | -7.14M (+702.25%) | -890.00K (-90.18%) | -9.06M (-28.38%) | -12.65M (-8.07%) | -13.76M | 590K (+145.83%) | 240K |
EBITDA | -1.34M (+1814.29%) | -70.00K (-95.33%) | -1.50M (-48.63%) | -2.92M (-8.18%) | -3.18M | 2.56M | -1.72M (-39.86%) | -2.86M (-71.08%) | -9.89M (+396.98%) | -1.99M | 17M | -7.61M (-19.81%) | -9.49M (-5.19%) | -10.01M (+5.26%) | -9.51M (+33.19%) | -7.14M (+711.36%) | -880.00K (-90.08%) | -8.87M (-29.88%) | -12.65M (-9.25%) | -13.94M | 590K (+145.83%) | 240K |
Other Income / Expenses | ||||||||||||||||||||||
Interest Expense | 890K (-24.58%) | 1.18M (+45.68%) | 810K (0.00%) | 810K (-8.99%) | 890K (-9.18%) | 980K (+46.27%) | 670K (+34.00%) | 500K (-9.09%) | 550K (+2650.00%) | 20K (-92.59%) | 270K (-64.47%) | 760K (+16.92%) | 650K (+4.84%) | 620K (+10.71%) | 560K (+24.44%) | 450K (+15.38%) | 390K (-90.49%) | 4.10M (+199.27%) | 1.37M (+2.24%) | 1.34M (+509.09%) | 220K | - |
Net Interest Income | - | - | - | - | - | 550K | - | - | -550.00K (+2650.00%) | -20.00K (-92.59%) | -270.00K (-64.47%) | -760.00K (+16.92%) | -650.00K (+4.84%) | -620.00K (+10.71%) | -560.00K (+24.44%) | -450.00K (+15.38%) | -390.00K (-90.49%) | -4.10M (+199.27%) | -1.37M (+2.24%) | -1.34M (+509.09%) | -220.00K | - |
Other Non Operating Income | -740.00K (-76.88%) | -3.20M (+305.06%) | -790.00K (-8.14%) | -860.00K (+14.67%) | -750.00K (-19.35%) | -930.00K | 500K | -430.00K (+22.86%) | -350.00K (-77.56%) | -1.56M (+333.33%) | -360.00K (-49.30%) | -710.00K (+24.56%) | -570.00K (-72.20%) | -2.05M (+253.45%) | -580.00K (+28.89%) | -450.00K (+15.38%) | -390.00K (-94.79%) | -7.48M (+445.99%) | -1.37M (-9.87%) | -1.52M (+590.91%) | -220.00K (+15.79%) | -190.00K |
Net Income | ||||||||||||||||||||||
Income Before Tax | -2.23M (+78.40%) | -1.25M (-45.89%) | -2.31M (-38.24%) | -3.74M (-8.11%) | -4.07M | 1.58M | -2.39M (-28.87%) | -3.36M (-67.82%) | -10.44M (+416.83%) | -2.02M | 17M | -8.36M (-17.55%) | -10.14M (-4.61%) | -10.63M (+5.56%) | -10.07M (+32.67%) | -7.59M (+497.64%) | -1.27M (-90.54%) | -13.42M (-4.28%) | -14.02M (-8.31%) | -15.29M | 360K (+620.00%) | 50K |
Income Tax Expense | - | - | - | 60K | - | 60K | - | - | - | 130K (+30.00%) | 100K | - | - | 10K (0.00%) | 10K | -60.00K | 100K (-98.80%) | 8.34M | -3.37M (-1.46%) | -3.42M | 100K (+400.00%) | 20K |
Net Income From Continuing Operations | -2.23M (+78.40%) | -1.25M (-45.89%) | -2.31M (-39.21%) | -3.80M (-6.63%) | -4.07M | 1.52M | -2.39M (-28.87%) | -3.36M (-67.82%) | -10.44M (+387.85%) | -2.14M | 17M | -8.36M (-17.55%) | -10.14M (-4.70%) | -10.64M (+5.56%) | -10.08M (+33.86%) | -7.53M (+445.65%) | -1.38M (-93.66%) | -21.75M (+104.23%) | -10.65M (-10.20%) | -11.86M | 270K (+800.00%) | 30K |
Net Income | -2.23M (+78.40%) | -1.25M (-45.89%) | -2.31M (-39.21%) | -3.80M (-6.63%) | -4.07M | 1.52M | -2.39M (-28.87%) | -3.36M (-67.82%) | -10.44M (+387.85%) | -2.14M | 17M | -8.36M (-17.55%) | -10.14M (-4.70%) | -10.64M (+5.56%) | -10.08M (+33.86%) | -7.53M (+445.65%) | -1.38M (-93.66%) | -21.75M (+104.23%) | -10.65M (-10.20%) | -11.86M | 270K (+800.00%) | 30K |